Theravance Biopharma, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (36)

Latest Posts

About This Stock More About This Stock
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
Article By: ChinaBio® Today
Saturday, November 18, 2023 2:00 PM EST
Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and commercialize the DLL3 group of cell therapies.
In this article: NVS, TBPH, LEGN, VTRS, APLM Also: WXXWY
Read
Wednesday Global Investing Report
Article By: Vivian Lewis
Wednesday, December 8, 2021 7:56 PM EST
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international companies in our portfolio.
In this article: CVE, GSK, MRK, NVO, PFE, VE, RHHBY, SSNLF, SZEVF, TMRAF, MELI, TSEM, MRNA, TBPH, KL, BNTX
Read
Monday Markets Unhinged
Article By: Vivian Lewis
Monday, May 3, 2021 4:54 PM EST
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.
In this article: CCJ, KL, AZRE, NIO, ESPR, TBPH, ZYME, AQN, AY, BHC, TAK, TEVA, OCGN
Read
Theravance Biopharma - Chart Of The Day
Article By: Jim Van Meerten
Tuesday, September 20, 2016 8:22 PM EST
Since the Trend spotter signaled a buy on 7/27 the sock gained 45.37%.
In this article: TBPH
Read
Theravance Bio - Sell Signals
Article By: Jim Van Meerten
Tuesday, May 10, 2016 10:45 PM EST
I recently deleted Theravance Bio from the Barchart Van Meerten New High portfolio for negative price momentum.
In this article: TBPH
Read

Latest Tweets for $TBPH

No tweets yet!

PARTNER HEADLINES